Patents Assigned to Adaptive Biologix, Inc.
  • Extracellular matrix compositions for the treatment of cancer or immunological diseases
    Patent number: 11191780
    Abstract: The present invention is directed to methods of inhibiting cancer cell growth or proliferation by contacting the cancer cell with an extracellular matrix (ECM) composition. Also provided are methods of delivering a chemotherapeutic agent to a cancer cell by contacting a cancer cell with an extracellular matrix composition containing a chemotherapeutic agent. Also provided are compositions containing ECM and a chemotherapeutic agent.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: December 7, 2021
    Assignee: Adaptive Biologix, Inc.
    Inventors: Gail K. Naughton, Frank Zeigler, Emmett Pinney
  • Extracellular matrix compositions for the treatment of cancer
    Patent number: 10675303
    Abstract: The present invention is directed to methods of inhibiting cancer cell growth or proliferation by contacting the cancer cell with an extracellular matrix (ECM) composition. Also provided are methods of delivering a chemotherapeutic agent to a cancer cell by contacting a cancer cell with an extracellular matrix composition containing a chemotherapeutic agent. Also provided are compositions containing ECM and a chemotherapeutic agent.
    Type: Grant
    Filed: November 30, 2018
    Date of Patent: June 9, 2020
    Assignee: Adaptive Biologix, Inc.
    Inventors: Gail K. Naughton, Emmett Pinney